Company
20/20 BioLabs
AI-Powered Blood Testing for Early Detection
- Business model
- B2C
Claim, correct or request removal
Record updated 28 September 2026
About
20/20 BioLabs develops next-generation diagnostic tests for cancer and chronic diseases using machine learning and real-world clinical data. Its affordable, lab-based blood tests combine high accuracy with consumer convenience—enabled by painless, upper-arm collection devices for at-home use. The company is democratizing access to early detection through scalable, actionable solutions.
Loading relationship preview